Shanghai Fengxian Manufacturing Site
64,480m2Total Factory
75.5m3Total Capacity
2NewAPIs Approved
Services
cGMP - Small Molecule
Porton offers efficient, flexible, and high-quality solutions for custom development and production of small molecule APIs, as well as technical services throughout the entire lifecycle from pre-clinical to commercial stages to our worldwide partners.
- PCC, GLP Tox, GMP
- IND, PV, NDA
- Up to 100+ Kg Scale API"
cGMP - Tides/HPs
With five major R&D platforms, including peptides, oligonucleotides, conjugated drugs, high-performance liquid chromatography, and Tides analysis, the Porton Tides CDMO Services Platform is committed to providing integrated CMC solutions for global customers, covering all types of new drugs from pre-clinical to commercial.
- Polypeptide, Oligonucleotide, Payload-Linker
- High Potent Compound Handling
- Lyophilization, RPC, etc.
One Porton One Quality
Compliance standards, Continuous improvement, Customer oriented
Quality management runs throughout the entire process of the drug life cycle. The quality management system of the drug product site is built in accordance with international standards and continues to adhere to the quality concept of 'more well-established system, more controllable quality.' This ensures that the GMP activities of the drug product site meet the requirements of international quality management systems and market drug regulatory agencies, including those of China, the European Union, FDA, and other mainstream regulations.
- Inspections from NPMA (2 API) in 2023
- 14+ Quality Audit from Clients in 2023
News
MoreNews2024-12-19
Porton Newsletter | Q4 2024 Recap
More
News2024-12-06
Porton Recognized as an Exemplary Case for Sustainable Development
More
News2024-12-06
Porton is thrilled to announce the launch of its newly redesigned official website
More
News2024-11-09
Porton’s New Modality Capacity Upgrade Ceremony Successfully Held
More
News2024-10-31
Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities
More
